Why Recently-Listed Haoxi Health Technology Shares Are Falling Today

Haoxi Health Technology experiences a decline in its shares after closing its initial public offering at $4.00 per share, raising $9.60 million for general purposes.

Haoxi Health Technology Limited (NASDAQ:HAO) shares are trading lower on Wednesday morning.

Yesterday, the company announced the closing of its initial public offering of 2.40 million Class A ordinary shares at an initial public offering price of $4.00 per share for total gross proceeds of $9.60 million.

The offering closed on January 30, 2024, and the ordinary shares began trading on Nasdaq Capital Market on January 26, 2024.

The company intends to use the proceeds from this offering for working capital and general corporate purposes; acquiring or investing in technologies, solutions, or businesses; and hiring experienced employees.

Over the last five days, shares of the Chinese firm jumped 43.41%, outpacing the broader S&P 500’s return of 0.74%.

According to Benzinga Pro, Haoxi Health’s top peers include The Trade Desk, Inc. (NASDAQ:TTD) (down 3.05% in the last 5 days) and Omnicom Group Inc. (NYSE:OMC), among others (up 1.53% in the last 5 days). 

Price Action: HAO shares are trading lower by 9.31% to $7.01 premarket on the last check Wednesday.

Image: Shutterstock/ Andrii Yalanskyi

Total
0
Shares
Related Posts
Read More

Catalyst Biosciences Announces Completion Of Business Combination With Beijing Continent Pharmaceuticals And Implementation Of Name Change And 1-For-15 Reverse Stock Split; Company Will Operate As Gyre Therapeutics, Inc. Under Trading Symbol “GYRE”

The combined company will operate as "Gyre Therapeutics, Inc." with its common stock traded on Nasdaq under trading symbol "GYRE" effective Tuesday, October 31, 2023 SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) --

CBIO